Engineered flavoprotein

Engineered flavoproteins are a diverse class of synthetic or modified proteins that utilize flavin cofactors, such as flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD), to perform specific biological or chemical functions. These proteins are often derived from naturally occurring light-oxygen-voltage (LOV) domains or flavoenzymes and are redesigned for applications in optogenetics, biocatalysis, and therapeutic imaging (Losi et al., 2018). In a clinical context, they are primarily explored as tools for precision medicine, such as light-activated triggers for gene expression or as targeted photosensitizers in photodynamic therapy to induce localized cell death in tumors (Shu et al., 2011). Because they are typically exogenous tools or therapeutic agents rather than endogenous human targets, their development focuses on optimizing cofactor binding, spectral properties, and minimizing immunogenicity (Piatkevich et al., 2013). Their role in disease is indirect, serving as the mechanism through which a therapeutic intervention is delivered rather than being the underlying cause of a pathology. Consequently, they are classified as therapeutic modalities or research tools rather than traditional drug targets.

Other names

Synthetic flavoproteinModified flavoenzymeOptogenetic flavoprotein actuatorFlavin-based fluorescent proteinminiSOGLOV-domain actuator

Engineered flavoproteins typically function as optogenetic actuators or biocatalysts; they are activated by light or specific substrates to modulate cellular signaling, induce apoptosis via reactive oxygen species production, or catalyze therapeutic prodrug conversion (Losi et al., 2018; Shu et al., 2011).